HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sameer Alshehri Selected Research

E 64

1/2022Examination of Charge Modifications of an Endolysosomal Trapping Inhibitor in an Antagonistic NTSR1-Targeted Construct for Colon Cancer.
9/2019Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sameer Alshehri Research Topics

Disease

6Neoplasms (Cancer)
04/2022 - 10/2018
2Colonic Neoplasms (Colon Cancer)
04/2022 - 01/2022
1Prostatic Neoplasms (Prostate Cancer)
10/2020

Drug/Important Bio-Agent (IBA)

5CathepsinsIBA
04/2022 - 10/2018
5Cysteine (L-Cysteine)FDA Link
04/2022 - 10/2018
3RadiopharmaceuticalsIBA
04/2022 - 09/2019
2Biological ProductsIBA
04/2022 - 01/2022
2Neurotensin Receptors (Neurotensin Receptor)IBA
04/2022 - 01/2022
2E 64IBA
01/2022 - 09/2019
1Bombesin Receptors (Bombesin Receptor)IBA
10/2020
1Peptides (Polypeptides)IBA
10/2020
1hydroxypropyl methacrylateIBA
10/2020
1BombesinIBA
10/2020